Metagenomi will be participating in Chardan’s 8th Annual Genetic Medicines Conference.

EMERYVILLE, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its…

Read More: https://www.globenewswire.com/news-release/2024/09/19/2949456/0/en/Metagenomi-to-Present-at-Chardan-s-8th-Annual-Genetic-Medicines-Conference.html